Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06899113

Correlating Multispectral Near-Infrared Imaging to Standard Vascular Diagnostics

The goal of this observational study is to learn if the measures of tissue oxygenation from the MIMOSA Pro imaging device correlate to standard vascular assessment tools in patients who receiving a lower extremity vascular assessment.

The main questions it aims to answer are:

* Do the MIMOSA Pro tissue oxygenation measures correlate to Ankle-Brachial Index, Toe-Brachial Index, transcutaneous oximetry, and Doppler wave forms? * Do the MIMOSA Pro tissue oxygenation measures correlate with disease classifications for peripheral arterial disease, venous disease, and wound stage? * Is the MIMOSA Pro able to measure vascular status more often than other modalities?

Participants will be asked to follow standard of care, and also allow for their legs to imaged by the MIMOSA Pro.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Northwell Health Comprehensive Wound Healing Center

Lake Success, New York, 11042, United States

Location status: Recruiting

Location contact

Amit Rao, MD

CONTACT

[email protected]

516-233-3661

About this study

Observational non-interventional study to assess the use of multispectral near-infrared (MS-NIR) imaging as an adjunct tool in the wound center. No clinical decisions will be made based on information obtained through the use of the MIMOSA device. Objectives are to correlate tissue oxygen saturation (StO2) by MS-NIR to measures by standard vascular diagnostic tools, including ankle-brachial index (ABI), toe-brachial index (TBI), transcutaneous oximetry, Doppler waveforms. Also to assess the ability of MS-NIR to support the classification and grading severity of patients' peripheral artery disease (PAD), venous disease and wound healing and to evaluate the clinical workflow utility of MS-NIR as an adjunct tool in the wound center. The study will recruit patients 18 years old and older, are undergoing an ankle-brachial index exam and recently had/will have further vascular assessment, as per standard of care (inc. transcutaneous oxygen pressure, Doppler waveforms). Participants will be asked to allow for imaging of their lower extremities with the MIMOSA Pro. Investigator will assess participants on their disease and wound status. They will also perform vascular assessments mentioned above as per standard of care. Participants will be followed for 2 months as per regularly scheduled visits. The standard vascular assessment results and disease/wound status will then be correlated with the measures from the MIMOSA Pro.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Male or female, aged 18 and older
  • Patient is undergoing an ABI test.
  • Patient recently had/will have further vascular assessment, as per standard of care (inc. transcutaneous oxygen pressure, Doppler waveforms)
  • Patients who can be followed by the same investigating team for the whole period of their participation in the study.

Exclusion criteria

  • Patients who are participating in another clinical study for ulcer management
  • Patients who are unable to understand the aims of the study and not able to provide informed consent
  • Receiving radiation to the extremity
  • Active charcot joints

Treatment and study plan

Primary outcomes

  1. Correlation coefficient between MIMOSA measures to standard vascular assessment modalities

    Time frame: From baseline to the end of study at 2 months

Secondary outcomes

  1. Correlation coefficient between MIMOSA measures to disease and/or wound status

    Time frame: From baseline to the end of study at 2 months

Study contacts

Contact information is provided by the study sponsor or research team.

Alisha Oropallo, MD

CONTACT

[email protected]

516-233-3780

Sponsors and collaborators

Lead sponsor

MIMOSA Diagnostics Inc.

Industry

Collaborators

  • Northwell Health

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Mar 27, 2025
Registry last updated
Sep 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.